New Advances in the Treatment and Diagnosis of Neuromuscular Diseases
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 350
Special Issue Editor
Special Issue Information
Dear Colleagues,
Recent progress in the diagnosis and treatment of neuromuscular diseases is transforming patient care. These disorders are now being approached with innovative therapies and advanced diagnostic tools.
Key breakthroughs involve the use of gene therapies, exon skipping with antisense oligonucleotides and CRISPR-Cas9 for gene editing. Additionally, the application of stem cell therapy is being explored to regenerate damaged muscle tissue and restore function. Pharmacological therapies promoting muscle growth and function are also showing promise, particularly when used in combination with genetic treatments.
Advancements in diagnostic techniques have revolutionized the field of neuromuscular diseases. Next-generation sequencing allows for rapid and precise identification of genetic mutations associated with various neuromuscular disorders. This not only facilitates early diagnosis but also enables personalized treatment plans tailored to individual genetic profiles. Recently discovered new biomarkers are also crucial, offering valuable tools for early diagnosis, disease progression monitoring, and treatment efficacy evaluation.
This Special Issue aims to provide a more comprehensive overview of these cutting-edge developments in the Treatment and Diagnosis of Neuromuscular Diseases.
We welcome both original research and review articles.
Dr. Silvia Consalvi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neuromuscular diseases
- gene therapies
- stem cell therapy
- treatment and diagnosis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
